^
    CANCER:

    Juvenile Myelomonocytic Leukemia





    Show legend
    Group by Gene:
    Include preclinical:

    0
    DNA methylation inhibitor
    azacitidine
    1
    MEK inhibitor
    trametinib
    2
    DNMT inhibitor
    decitabine
    3
    Multi-tyrosine kinase inhibitor
    gilteritinib
    No biomarker
    PTPN11 mutation
    KRAS mutation
    ETV6-FLT3 fusion
    SETBP1 mutation + NRAS mutation